Death Reporting in Breakthrough and Unvaccinated SARS-CoV-2 Infection Cases
Vaccines are undeniably an important tool for controlling infectious disease outbreaks, and they are the most certain way to end the epidemic risk. This brief report describes the characteristics of coronavirus disease 2019 (COVID-19) deaths among breakthrough and unvaccinated cases hospitalized in...
Gespeichert in:
| Veröffentlicht in: | Disaster medicine and public health preparedness 2023-03, Vol.17, p.e359-e359, Article e359 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | e359 |
|---|---|
| container_issue | |
| container_start_page | e359 |
| container_title | Disaster medicine and public health preparedness |
| container_volume | 17 |
| creator | Emami, Amir Javanmardi, Fatemeh Bakhtiari, Hamid Rezaei, Tahereh Hemmati, Abdolrasoul Akbari, Ali Pirbonyeh, Neda |
| description | Vaccines are undeniably an important tool for controlling infectious disease outbreaks, and they are the most certain way to end the epidemic risk. This brief report describes the characteristics of coronavirus disease 2019 (COVID-19) deaths among breakthrough and unvaccinated cases hospitalized in Fars province in the south of Iran. This cross-sectional study was performed to compare breakthrough and unvaccinated death cases in Fars, Iran (February 2, to August 19, 2021). Among 444,728 fully vaccinated people, 60,800 breakthrough cases were detected. Thus, 501 died, of which 297 (297/501) cases were hospitalized and compared with the unvaccinated dead group. The median age for breakthrough and unvaccinated cases was estimated 79 and 65 y, respectively. All signs and symptoms of COVID-19 were more frequent in the unvaccinated group. Decreasing O2 saturation (less than 93%) happened more often in the unvaccinated group significantly. Unvaccinated dead patients had significantly shorter hospital stays. These patients received 66.63% Sinopharm, 0.67% Sputnik, 0.67% COVIran Barekat, and 31.99% AstraZeneca vaccines. None of them were health-care staff. Equitable access to safe and effective vaccines is critical to ending the COVID-19 pandemic. As vaccine uptake increases, we observed a decrease in mortality and protection from severe forms of the disease. |
| doi_str_mv | 10.1017/dmp.2023.4 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2788797076</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cupid>10_1017_dmp_2023_4</cupid><sourcerecordid>2788333620</sourcerecordid><originalsourceid>FETCH-LOGICAL-c347t-d629ced77b1535b325306739995c417e2d860b2c23602e3cf03f6fb211d16aba3</originalsourceid><addsrcrecordid>eNpt0F1LwzAUBuAgipvTG3-AFLwRsTMfbdJczvqJA2Fz4l1Jk3TrXJOZtIL_3u5DBfHqnIuH9xxeAI4R7COI2KWqln0MMelHO6CLOElCFkWvu-s9DlnCSQcceD-HMKYs5vugQ2irOKRd8HitRT0LRnppXV2aaVCa4Mpp8VbPnG2ms0AYFUzMh5CyNKLWKhgPRuMwtS8hDh5MoWVdWhOkwmt_CPYKsfD6aDt7YHJ785zeh8Onu4d0MAwliVgdKoq51IqxHMUkzgmOCaSMcM5jGSGmsUoozLHEhEKsiSwgKWiRY4QUoiIXpAfONrlLZ98b7eusKr3Ui4Uw2jY-wyxJGGeQ0Zae_qFz2zjTfrdWhBCKYavON0o6673TRbZ0ZSXcZ4Zgtqo4ayvOVhVnUYtPtpFNXmn1Q787bcHFNk1UuSvVVP8e_SfvCycoguU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2788333620</pqid></control><display><type>article</type><title>Death Reporting in Breakthrough and Unvaccinated SARS-CoV-2 Infection Cases</title><source>MEDLINE</source><source>Cambridge University Press Journals Complete</source><creator>Emami, Amir ; Javanmardi, Fatemeh ; Bakhtiari, Hamid ; Rezaei, Tahereh ; Hemmati, Abdolrasoul ; Akbari, Ali ; Pirbonyeh, Neda</creator><creatorcontrib>Emami, Amir ; Javanmardi, Fatemeh ; Bakhtiari, Hamid ; Rezaei, Tahereh ; Hemmati, Abdolrasoul ; Akbari, Ali ; Pirbonyeh, Neda</creatorcontrib><description>Vaccines are undeniably an important tool for controlling infectious disease outbreaks, and they are the most certain way to end the epidemic risk. This brief report describes the characteristics of coronavirus disease 2019 (COVID-19) deaths among breakthrough and unvaccinated cases hospitalized in Fars province in the south of Iran. This cross-sectional study was performed to compare breakthrough and unvaccinated death cases in Fars, Iran (February 2, to August 19, 2021). Among 444,728 fully vaccinated people, 60,800 breakthrough cases were detected. Thus, 501 died, of which 297 (297/501) cases were hospitalized and compared with the unvaccinated dead group. The median age for breakthrough and unvaccinated cases was estimated 79 and 65 y, respectively. All signs and symptoms of COVID-19 were more frequent in the unvaccinated group. Decreasing O2 saturation (less than 93%) happened more often in the unvaccinated group significantly. Unvaccinated dead patients had significantly shorter hospital stays. These patients received 66.63% Sinopharm, 0.67% Sputnik, 0.67% COVIran Barekat, and 31.99% AstraZeneca vaccines. None of them were health-care staff. Equitable access to safe and effective vaccines is critical to ending the COVID-19 pandemic. As vaccine uptake increases, we observed a decrease in mortality and protection from severe forms of the disease.</description><identifier>ISSN: 1935-7893</identifier><identifier>EISSN: 1938-744X</identifier><identifier>DOI: 10.1017/dmp.2023.4</identifier><identifier>PMID: 36938906</identifier><language>eng</language><publisher>New York, USA: Cambridge University Press</publisher><subject>Age ; Coronaviruses ; COVID-19 ; COVID-19 - epidemiology ; COVID-19 vaccines ; Cross-Sectional Studies ; Disease control ; Disease Outbreaks ; Disease transmission ; Epidemics ; FDA approval ; Hospitalization ; Humans ; Infectious diseases ; Mortality ; Original Research ; Pandemics ; Public health ; SARS-CoV-2 ; Severe acute respiratory syndrome coronavirus 2 ; Vaccines ; Viral infections</subject><ispartof>Disaster medicine and public health preparedness, 2023-03, Vol.17, p.e359-e359, Article e359</ispartof><rights>The Author(s), 2023. Published by Cambridge University Press on behalf of Society for Disaster Medicine and Public Health, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c347t-d629ced77b1535b325306739995c417e2d860b2c23602e3cf03f6fb211d16aba3</cites><orcidid>0000-0001-8841-0861 ; 0000-0001-5700-3913 ; 0000-0002-2970-2052 ; 0000-0002-4510-1820</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.cambridge.org/core/product/identifier/S1935789323000046/type/journal_article$$EHTML$$P50$$Gcambridge$$H</linktohtml><link.rule.ids>164,314,780,784,27924,27925,55628</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36938906$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Emami, Amir</creatorcontrib><creatorcontrib>Javanmardi, Fatemeh</creatorcontrib><creatorcontrib>Bakhtiari, Hamid</creatorcontrib><creatorcontrib>Rezaei, Tahereh</creatorcontrib><creatorcontrib>Hemmati, Abdolrasoul</creatorcontrib><creatorcontrib>Akbari, Ali</creatorcontrib><creatorcontrib>Pirbonyeh, Neda</creatorcontrib><title>Death Reporting in Breakthrough and Unvaccinated SARS-CoV-2 Infection Cases</title><title>Disaster medicine and public health preparedness</title><addtitle>Disaster med. public health prep</addtitle><description>Vaccines are undeniably an important tool for controlling infectious disease outbreaks, and they are the most certain way to end the epidemic risk. This brief report describes the characteristics of coronavirus disease 2019 (COVID-19) deaths among breakthrough and unvaccinated cases hospitalized in Fars province in the south of Iran. This cross-sectional study was performed to compare breakthrough and unvaccinated death cases in Fars, Iran (February 2, to August 19, 2021). Among 444,728 fully vaccinated people, 60,800 breakthrough cases were detected. Thus, 501 died, of which 297 (297/501) cases were hospitalized and compared with the unvaccinated dead group. The median age for breakthrough and unvaccinated cases was estimated 79 and 65 y, respectively. All signs and symptoms of COVID-19 were more frequent in the unvaccinated group. Decreasing O2 saturation (less than 93%) happened more often in the unvaccinated group significantly. Unvaccinated dead patients had significantly shorter hospital stays. These patients received 66.63% Sinopharm, 0.67% Sputnik, 0.67% COVIran Barekat, and 31.99% AstraZeneca vaccines. None of them were health-care staff. Equitable access to safe and effective vaccines is critical to ending the COVID-19 pandemic. As vaccine uptake increases, we observed a decrease in mortality and protection from severe forms of the disease.</description><subject>Age</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>COVID-19 - epidemiology</subject><subject>COVID-19 vaccines</subject><subject>Cross-Sectional Studies</subject><subject>Disease control</subject><subject>Disease Outbreaks</subject><subject>Disease transmission</subject><subject>Epidemics</subject><subject>FDA approval</subject><subject>Hospitalization</subject><subject>Humans</subject><subject>Infectious diseases</subject><subject>Mortality</subject><subject>Original Research</subject><subject>Pandemics</subject><subject>Public health</subject><subject>SARS-CoV-2</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Vaccines</subject><subject>Viral infections</subject><issn>1935-7893</issn><issn>1938-744X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNpt0F1LwzAUBuAgipvTG3-AFLwRsTMfbdJczvqJA2Fz4l1Jk3TrXJOZtIL_3u5DBfHqnIuH9xxeAI4R7COI2KWqln0MMelHO6CLOElCFkWvu-s9DlnCSQcceD-HMKYs5vugQ2irOKRd8HitRT0LRnppXV2aaVCa4Mpp8VbPnG2ms0AYFUzMh5CyNKLWKhgPRuMwtS8hDh5MoWVdWhOkwmt_CPYKsfD6aDt7YHJ785zeh8Onu4d0MAwliVgdKoq51IqxHMUkzgmOCaSMcM5jGSGmsUoozLHEhEKsiSwgKWiRY4QUoiIXpAfONrlLZ98b7eusKr3Ui4Uw2jY-wyxJGGeQ0Zae_qFz2zjTfrdWhBCKYavON0o6673TRbZ0ZSXcZ4Zgtqo4ayvOVhVnUYtPtpFNXmn1Q787bcHFNk1UuSvVVP8e_SfvCycoguU</recordid><startdate>20230320</startdate><enddate>20230320</enddate><creator>Emami, Amir</creator><creator>Javanmardi, Fatemeh</creator><creator>Bakhtiari, Hamid</creator><creator>Rezaei, Tahereh</creator><creator>Hemmati, Abdolrasoul</creator><creator>Akbari, Ali</creator><creator>Pirbonyeh, Neda</creator><general>Cambridge University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8C1</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-8841-0861</orcidid><orcidid>https://orcid.org/0000-0001-5700-3913</orcidid><orcidid>https://orcid.org/0000-0002-2970-2052</orcidid><orcidid>https://orcid.org/0000-0002-4510-1820</orcidid></search><sort><creationdate>20230320</creationdate><title>Death Reporting in Breakthrough and Unvaccinated SARS-CoV-2 Infection Cases</title><author>Emami, Amir ; Javanmardi, Fatemeh ; Bakhtiari, Hamid ; Rezaei, Tahereh ; Hemmati, Abdolrasoul ; Akbari, Ali ; Pirbonyeh, Neda</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c347t-d629ced77b1535b325306739995c417e2d860b2c23602e3cf03f6fb211d16aba3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Age</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>COVID-19 - epidemiology</topic><topic>COVID-19 vaccines</topic><topic>Cross-Sectional Studies</topic><topic>Disease control</topic><topic>Disease Outbreaks</topic><topic>Disease transmission</topic><topic>Epidemics</topic><topic>FDA approval</topic><topic>Hospitalization</topic><topic>Humans</topic><topic>Infectious diseases</topic><topic>Mortality</topic><topic>Original Research</topic><topic>Pandemics</topic><topic>Public health</topic><topic>SARS-CoV-2</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Vaccines</topic><topic>Viral infections</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Emami, Amir</creatorcontrib><creatorcontrib>Javanmardi, Fatemeh</creatorcontrib><creatorcontrib>Bakhtiari, Hamid</creatorcontrib><creatorcontrib>Rezaei, Tahereh</creatorcontrib><creatorcontrib>Hemmati, Abdolrasoul</creatorcontrib><creatorcontrib>Akbari, Ali</creatorcontrib><creatorcontrib>Pirbonyeh, Neda</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Public Health Database</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>Disaster medicine and public health preparedness</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Emami, Amir</au><au>Javanmardi, Fatemeh</au><au>Bakhtiari, Hamid</au><au>Rezaei, Tahereh</au><au>Hemmati, Abdolrasoul</au><au>Akbari, Ali</au><au>Pirbonyeh, Neda</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Death Reporting in Breakthrough and Unvaccinated SARS-CoV-2 Infection Cases</atitle><jtitle>Disaster medicine and public health preparedness</jtitle><addtitle>Disaster med. public health prep</addtitle><date>2023-03-20</date><risdate>2023</risdate><volume>17</volume><spage>e359</spage><epage>e359</epage><pages>e359-e359</pages><artnum>e359</artnum><issn>1935-7893</issn><eissn>1938-744X</eissn><abstract>Vaccines are undeniably an important tool for controlling infectious disease outbreaks, and they are the most certain way to end the epidemic risk. This brief report describes the characteristics of coronavirus disease 2019 (COVID-19) deaths among breakthrough and unvaccinated cases hospitalized in Fars province in the south of Iran. This cross-sectional study was performed to compare breakthrough and unvaccinated death cases in Fars, Iran (February 2, to August 19, 2021). Among 444,728 fully vaccinated people, 60,800 breakthrough cases were detected. Thus, 501 died, of which 297 (297/501) cases were hospitalized and compared with the unvaccinated dead group. The median age for breakthrough and unvaccinated cases was estimated 79 and 65 y, respectively. All signs and symptoms of COVID-19 were more frequent in the unvaccinated group. Decreasing O2 saturation (less than 93%) happened more often in the unvaccinated group significantly. Unvaccinated dead patients had significantly shorter hospital stays. These patients received 66.63% Sinopharm, 0.67% Sputnik, 0.67% COVIran Barekat, and 31.99% AstraZeneca vaccines. None of them were health-care staff. Equitable access to safe and effective vaccines is critical to ending the COVID-19 pandemic. As vaccine uptake increases, we observed a decrease in mortality and protection from severe forms of the disease.</abstract><cop>New York, USA</cop><pub>Cambridge University Press</pub><pmid>36938906</pmid><doi>10.1017/dmp.2023.4</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0001-8841-0861</orcidid><orcidid>https://orcid.org/0000-0001-5700-3913</orcidid><orcidid>https://orcid.org/0000-0002-2970-2052</orcidid><orcidid>https://orcid.org/0000-0002-4510-1820</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1935-7893 |
| ispartof | Disaster medicine and public health preparedness, 2023-03, Vol.17, p.e359-e359, Article e359 |
| issn | 1935-7893 1938-744X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2788797076 |
| source | MEDLINE; Cambridge University Press Journals Complete |
| subjects | Age Coronaviruses COVID-19 COVID-19 - epidemiology COVID-19 vaccines Cross-Sectional Studies Disease control Disease Outbreaks Disease transmission Epidemics FDA approval Hospitalization Humans Infectious diseases Mortality Original Research Pandemics Public health SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Vaccines Viral infections |
| title | Death Reporting in Breakthrough and Unvaccinated SARS-CoV-2 Infection Cases |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T05%3A55%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Death%20Reporting%20in%20Breakthrough%20and%20Unvaccinated%20SARS-CoV-2%20Infection%20Cases&rft.jtitle=Disaster%20medicine%20and%20public%20health%20preparedness&rft.au=Emami,%20Amir&rft.date=2023-03-20&rft.volume=17&rft.spage=e359&rft.epage=e359&rft.pages=e359-e359&rft.artnum=e359&rft.issn=1935-7893&rft.eissn=1938-744X&rft_id=info:doi/10.1017/dmp.2023.4&rft_dat=%3Cproquest_cross%3E2788333620%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2788333620&rft_id=info:pmid/36938906&rft_cupid=10_1017_dmp_2023_4&rfr_iscdi=true |